MedTech CDMO Market – Global Outlook & Forecast 2021-2031

MedTech CDMO Market by Application [Drug Delivery & Fluid Management, Cardiovascular, Orthopedics, In-Vitro Diagnostics, Surgery Devices, Respiratory Care and Medical Imaging] – Global Analysis & Forecast 2021-2031

Clairvoyance conducted an in-depth market analysis study of the global MedTech CDMO market. According to the study, the market was valued at ~US$ 58.83 billion in 2020. The market is expected to witness a CAGR of ~11.0% from 2021 to 2031.

The global MedTech CDMO market is mainly driven by cost savings offered by MedTech CDMOs as compared to in-house manufacturing of medical device original equipment manufacturers (OEMs). Technological capabilities, scalability and risk diversification are other key factors driving the MedTech CDMO market.

Increasing prevalence of chronic & infectious diseases, growing geriatric population, growing consolidation - mergers & acquisition, technological advancements, convergence of technology platforms and rising investments are some of the other influencing factors that are augmenting the demand of MedTech contract manufacturing. However, trend of retaining high-value and IP-sensitive technologies in-house by MedTech OEMs, defective device recalls and stringent regulatory framework are likely to hinder the growth of the market to a certain extent. 

Growth in the MedTech CDMO market follows the growth patterns in the medical device industry but is outpacing growth of the device industry as a whole. Intensifying competition in the industry, stringent regulations and effects of a global COVID-19 pandemic has forced device manufacturers to recalibrate their strategies and explore new efficiencies in product design, development, manufacturing and marketing. MedTech companies are adopting strategy of outsourced manufacturing and are shifting their focus on marketing, branding & making products viable. Contract manufacturing provides MedTech companies number of strategic benefits such as curtailed product acquisition cost, efficient & quick product launch, allows them to focus on core competencies and provides access to specialized capabilities.

The MedTech CDMO market is a highly fragmented market and is marked by presence of prominent players such as Jabil, Flex, Integer, Vivify Health, Gerresheimer, Idex Corporation, Philips Medisize/Molex, Viant, Tecomet, TE Connectivity, Plexus, Tegra Medical, Confluent Medical Technologies, Seisa Medical, Celestica, Plexus, Nolato, Nemera, Lisi Medical, RTI Surgical, Heraeus Medical Components, Nordson Medical, Resonetics, Norwood Medical, Flambeau Medical Markets Group, Freudenberg Medical, Cadence, KLINGEL medical metal GmbH, Elos MedTech, Sanmina Corporation, among others.

In recent years, there has been number of merger and acquisition activities amongst prominent players in the industry to be competitive in the market. Prominent players are adopting inorganic growth strategies either to extend their range of services and offer one-stop-shop solution or to enter into another segment/region. Serving as one-stop-shop solution provider allows MedTech CDMOs to manage multiple phases of the product lifecycle and ensure large volume manufacturing with reliable quality, thereby allowing company to stand out among other companies. For instance, in Mar 2020, SHL Medical, a pioneer and technology frontrunner in the self-injection industry acquired Weibel CDS, a medical technology company which offers products & solutions for drug delivery and novel packaging.

About Us

Clairvoyance Research is a leading market research and consulting firm, based out in Kolkata, India. Our research solutions are structured around the following verticals: Healthcare (Medical Devices, Biotechnology, Healthcare IT, Pharmaceuticals, and Others), Food & Beverage, Consumer Goods, Automotive & Transportation, Chemicals & Materials & Others.
Our main offerings are syndicate reports and consulting assignments – We track a number of verticals and strategically publish syndicate reports on topics that have traction in the market. Over the years, we have developed a forte in executing consulting assignments – Clairvoyance Research has been a trusted partner to over 300 global organizations including Fortune 500 companies. We partner with clients from across the globe to identify their highest-value opportunities, address their most critical challenges, and transform their enterprises. We have a rich pool of clientele spanning leading medical device/biotechnology/healthcare IT/pharmaceutical companies, IT/FMCG/automotive/food & beverage companies, consulting companies, private equity firms, venture capitalists, investment banks, government bodies, academic/research institutes, and universities.
We internally house one of the best talents in the industry – Industry Veterans [Subject Matter Experts (SMEs), Key Opinion Leaders (KOLs)] from different verticals with a profound experience of several decades are there on our panel. At each stage of the study, these experts add value to our reports and consulting assignments. We nurture crème de la crème resources; our analysts/consultants come from robust educational backgrounds. The rich pool of experts and analysts/consultants at Clairvoyance Research ensures that the final research study is accurate, universally accepted, and of the highest quality.


Contact Us


Latest Reports

Popular Reports

Summer 3E,Purti Season,22 Buroshibtalla Main Road, Near Leela Petrol Pump, Kolkata, West Bengal-700038
+ 91 8761988338
10 AM to 10 PM
Support line